CEO Cornerstone
Applications Open For Upcoming Cohort
About
A peer-to-peer leadership development program uniquely tailored to the needs of today’s life science CEO. The program features monthly sessions, sophisticated content, guest experts and seasoned facilitators from The Leadership Edge. The program is designed to start powerful conversations among industry CEOs.
Why CEO Cornerstone
Customized Programming for Life Science CEOs
Exclusive, research-guided and highly relevant content that will enable CEOs to reach their full potential and navigate the industry’s unique challenges.
Access and Insights from Guest Experts
C-level executives, bankers and board members with relevant experience in the session topics are invited to share their insights and enrich the discussion.
A Forum Facilitated by Life Science Executive Coaches
Leveraging their industry knowledge, these coaches excel at facilitating meaningful conversations with life science CEOs.
Find the Right Cohort for You
The program is structured into cohorts of no more than 15 CEOs each. Each cohort is designed to ensure participants find the interactions meaningful and that they are among peers from companies at similar stages of development.
While many factors are considered for selection criteria and placement in each cohort, below are some general guidelines for participants.
Startup Stage
- First-time life science CEOs
- Pre-Series A
- Privately held companies
- Monthly sessions
Rolling applications. Each cohort is limited to 15 participants.
*Dates to be confirmed
Venture Stage
- First-time life science CEOs
- VC funded: Series A-C
- Privately held companies
- Monthly sessions
Rolling applications. Each cohort is limited to 15 participants.
Now accepting applications for Q1 2025.
Growth Stage
- Life science CEOs
- VC funded: Series D+
- Public and privately held companies
- Monthly sessions
Rolling applications. Each cohort is limited to 15 participants.
*Dates to be confirmed
experts
Guest Experts
Jim Birchenough
Chairman and Global Co-Head, Barclays Biopharmaceutical Investment Banking
Raising Capital
Steve Holtzman
Former CEO, Decibel Therapeutics
Building a Culture of Engagement, Innovation and Success
program-outline
Program Outline
Partnering with The Leadership Edge
For the past three decades, The Leadership Edge has had the distinct privilege of working exclusively within the Life Science industry. Our experience in developing over 7,500 scientific leaders in over 1,000 companies has resulted in an extensive knowledge of the industry, its people, processes, and markets. It’s been greatly rewarding to improve the pace, performance, and culture of the most innovative companies in the world.